These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 37038054)
1. Management of locally advanced intrahepatic cholangiocarcinoma: a narrative review. Bressler L; Bath N; Manne A; Miller E; Cloyd JM Chin Clin Oncol; 2023 Apr; 12(2):15. PubMed ID: 37038054 [TBL] [Abstract][Full Text] [Related]
2. Surgery and hepatic artery infusion therapy for intrahepatic cholangiocarcinoma. Scott A; Wong P; Melstrom LG Surgery; 2023 Jul; 174(1):113-115. PubMed ID: 36906437 [TBL] [Abstract][Full Text] [Related]
3. [Local and locoregional treatment of intrahepatic cholangiocarcinoma]. Wacker F; Dewald C Radiologe; 2022 Mar; 62(3):247-252. PubMed ID: 34981129 [TBL] [Abstract][Full Text] [Related]
5. Significant response to transarterial chemoembolization combined with PD-1 inhibitor and apatinib for advanced intrahepatic cholangiocarcinoma: A case report and literature review. Zhang H; Han C; Zheng X; Zhao W; Liu Y; Ye X J Cancer Res Ther; 2023 Aug; 19(4):1055-1060. PubMed ID: 37675736 [TBL] [Abstract][Full Text] [Related]
6. [Recent progress in molecular targeted therapies for intrahepatic cholangiocarcinoma]. Xie ZH; Li J; Xia Y; Shen F Zhonghua Wai Ke Za Zhi; 2020 Apr; 58(4):289-294. PubMed ID: 32241059 [TBL] [Abstract][Full Text] [Related]
11. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis. Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787 [No Abstract] [Full Text] [Related]
12. [Progress on surgical treatment of intrahepatic cholangiocarcinoma]. Shen F; Xie ZH; Xia Y; Wu MC Zhonghua Wai Ke Za Zhi; 2019 Apr; 57(4):241-246. PubMed ID: 30929367 [TBL] [Abstract][Full Text] [Related]
13. The multidisciplinary management of cholangiocarcinoma. Ohaegbulam KC; Koethe Y; Fung A; Mayo SC; Grossberg AJ; Chen EY; Sharzehi K; Kardosh A; Farsad K; Rocha FG; Thomas CR; Nabavizadeh N Cancer; 2023 Jan; 129(2):184-214. PubMed ID: 36382577 [TBL] [Abstract][Full Text] [Related]
14. Conventional and drug-eluting beads transarterial chemoembolization in patients with unresectable intrahepatic cholangiocarcinoma: a systematic review and pooled analysis. He M; Jiang N; Yin X; Xu A; Mu K J Cancer Res Clin Oncol; 2023 Jan; 149(1):531-540. PubMed ID: 36402872 [TBL] [Abstract][Full Text] [Related]
15. Transarterial Chemoembolization and Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma-a Systemic Review and Meta-Analysis. Mosconi C; Solaini L; Vara G; Brandi N; Cappelli A; Modestino F; Cucchetti A; Golfieri R Cardiovasc Intervent Radiol; 2021 May; 44(5):728-738. PubMed ID: 33709272 [TBL] [Abstract][Full Text] [Related]
16. Current status and perspectives in the surgical and oncological management of intrahepatic cholangiocarcinoma. Dhote A; Tzedakis S; Shapira OI; Nassar A; Boudjema K; Fuks D J Visc Surg; 2023 Oct; 160(5):346-355. PubMed ID: 37563006 [TBL] [Abstract][Full Text] [Related]